Get the Stockscreener App
21.23
2.46%
0.52
Privia Health Group Inc stock is traded at $21.23, with a volume of 333.20K.
It is up +2.46% in the last 24 hours and up +2.81% over the past month.
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
See More
Previous Close:
$20.71
Open:
$20.8
24h Volume:
333.20K
Relative Volume:
0.36
Market Cap:
$2.60B
Revenue:
$1.80B
Net Income/Loss:
$15.62M
P/E Ratio:
176.92
EPS:
0.12
Net Cash Flow:
$118.36M
1W Performance:
+3.11%
1M Performance:
+2.81%
6M Performance:
-15.93%
1Y Performance:
+8.65%
1-Day Range:
$20.80
$21.30
1-Week Range:
$20.05
$21.30
52-Week Range:
$16.47
$26.09
Privia Health Group Inc Stock (PRVA) Company Profile
Name
Privia Health Group Inc
Sector
Industry
Phone
571-366-8850
Address
950 N. GLEBE RD., SUITE 700, ARLINGTON
Compare PRVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
21.22 | 2.58B | 1.80B | 15.62M | 118.36M | 0.12 |
|
VEEV
Veeva Systems Inc
|
280.30 | 45.62B | 2.86B | 780.66M | 1.19B | 4.72 |
|
TEM
Tempus Ai Inc
|
74.63 | 12.10B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
65.07 | 11.99B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.48 | 7.72B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.78 | 6.16B | 906.14M | -52.62M | 89.62M | -0.3621 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-16-24 | Initiated | Macquarie | Outperform |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Resumed | Jefferies | Buy |
| Feb-22-24 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Jun-13-23 | Initiated | Evercore ISI | Outperform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Mar-10-23 | Initiated | RBC Capital Mkts | Outperform |
| Feb-03-23 | Initiated | Goldman | Buy |
| Dec-09-22 | Initiated | Stifel | Buy |
| Dec-08-22 | Initiated | UBS | Buy |
| Sep-07-22 | Resumed | Truist | Buy |
| May-03-22 | Initiated | BofA Securities | Buy |
| Apr-28-22 | Initiated | BTIG Research | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Feb-22-22 | Upgrade | Cowen | Market Perform → Outperform |
| Jan-03-22 | Initiated | Jefferies | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| May-24-21 | Initiated | Canaccord Genuity | Buy |
| May-24-21 | Initiated | Credit Suisse | Outperform |
| May-24-21 | Initiated | JP Morgan | Overweight |
| May-24-21 | Initiated | Piper Sandler | Overweight |
| May-24-21 | Initiated | Truist | Buy |
| May-24-21 | Initiated | William Blair | Outperform |
View All
Privia Health Group Inc Stock (PRVA) Latest News
We Think Privia Health Group's (NASDAQ:PRVA) Healthy Earnings Might Be Conservative - simplywall.st
Statistical indicators supporting Privia Health Group Inc.’s strengthOptions Play & Free Community Supported Trade Ideas - Newser
Sentiment analysis tools applied to Privia Health Group Inc.2025 Historical Comparison & Weekly Top Gainers Trade List - Newser
What recovery options are there for Privia Health Group Inc.Weekly Trading Summary & Community Verified Trade Signals - Newser
News impact scoring models applied to Privia Health Group Inc.Rate Cut & Weekly High Potential Stock Alerts - Newser
Privia Health Group Inc. stock prediction for this weekMarket Volume Summary & AI Enhanced Trading Alerts - Newser
Detecting price anomalies in Privia Health Group Inc. with AITrade Volume Summary & High Conviction Buy Zone Alerts - Newser
Privia Health Group (PRVA) Is Up 6.3% After Raising Full-Year Revenue Outlook—Has the Bull Case Changed? - simplywall.st
5 Must-Read Analyst Questions From Privia Health’s Q2 Earnings Call - Yahoo Finance
Privia Health’s SWOT analysis: capital-efficient model drives stock growth - Investing.com
Privia Health Group Inc. stock daily chart insightsWeekly Profit Report & Detailed Earnings Play Strategies - Newser
Piper Sandler Has Lowered Expectations for Privia Health Group (NASDAQ:PRVA) Stock Price - Defense World
Privia Health’s Earnings Call Highlights Robust Growth - TipRanks
Will Privia Health Group Inc. see short term momentum2025 Retail Activity & Target Return Focused Stock Picks - Newser
Truist Financial Maintains Privia Health(PRVA.US) With Buy Rating, Announces Target Price $30 - 富途牛牛
Barclays Maintains Hold Rating for Privia Health Group with $21 Target - AInvest
Undervalued Stocks for Investment: U.S. Market Fluctuations and Discounts Up to 48.8% - AInvest
3 Stocks Estimated To Be Trading At Discounts Up To 48.8% - Yahoo Finance
Privia Health Group (PRVA) Gets a Buy from Piper Sandler - The Globe and Mail
Natixis Advisors LLC Buys 2,342 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
PRVA Q2 Deep Dive: Platform Growth, Provider Expansion, and Margin Stability Drive Outperformance - Yahoo Finance
Key metrics from Privia Health Group Inc.’s quarterly dataTechnical Entry Plan with Risk Minimization - Newser
Piper Sandler Maintains Privia Health(PRVA.US) With Buy Rating, Cuts Target Price to $35 - 富途牛牛
Piper Sandler lowers Privia Health stock price target to $35 from $36 - Investing.com Nigeria
Privia Health: Piper Sandler maintains Overweight with PT down to $35 from $36. - AInvest
Cetera Investment Advisers Acquires 2,338 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Volume Surge May Signal Institutional Interest in Privia Health Group Inc.Weekly Stock Opportunity Radar Scanner Activated - beatles.ru
Privia Health Group shares rise 5.33% intraday after Q2 2025 earnings call. - AInvest
Privia Health Group Maintains Buy Rating and $32 Price Target - AInvest
Privia Health Group Stocks Surge Amid Strong Q2 Results - TipRanks
Privia Health Group: Strong Performance and Promising Outlook Justify Buy Rating - TipRanks
Privia Health: Q2 Earnings Snapshot - Greenwich Time
Avantax Advisory Services Inc. Boosts Stake in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health raises 2025 outlook above prior range as implemented providers climb 13.8% and value-based lives grow 15.2% - MSN
Privia Health Reports Strong Q2 2025 Financial Results - TipRanks
Privia Health's Q2 2025 Earnings: Navigating Earnings Disappointments While Fueling Sustainable Growth - AInvest
Transcript : Privia Health Group, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Privia Health Group: Strong Buy Rating Backed by Robust Financial Performance and Strategic Expansion - TipRanks
Privia Health shares rise 2.10% after-hours after reporting Q2 revenue of $521.2M, beating estimates. - AInvest
Privia Health (NASDAQ:PRVA) Reports Upbeat Q2 - Yahoo Finance
Privia Health Group shares fall 2.25% intraday after missing Q2 earnings expectations. - AInvest
Privia Health Group Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: Privia Health Q2 2025 misses EPS expectations - Investing.com India
Compared to Estimates, Privia Health (PRVA) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
Privia Health Group, Inc. SEC 10-Q Report - TradingView
Privia Health Group earnings missed by $0.03, revenue topped estimates - Investing.com Canada
Privia Health (PRVA) Misses Q2 Earnings Estimates - Yahoo Finance
Privia Health Group Stocks Surge on Strong Outlook - TipRanks
Privia Health Q2 2025 slides: Strong growth and raised guidance, but shares plunge - Investing.com
Privia Health Q2 revenue misses estimates - MarketScreener
Privia Health Reports Second Quarter 2025 Financial Results - The Manila Times
Privia Health Group Inc Stock (PRVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
7.72%
0.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):